Skip to main content
SpringerLink
Log in

Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The relationship between serum and biliary concentrations of bile acids was studied in 20 rhesus monkeys which developed hepatotoxicity after six months of treatment with 40 and 120 mg/kg/day doses of chenodeoxycholic (cheno) and ursodeoxycholic (urso) acids, respectively. During the treatment, lithocholate—all of which was unsulfated—increased several-fold both in serum and in bile. There was a significant correlation between serum and biliary concentrations of lithocholate. Similarly close correlations existed between the serum and biliary concentrations of the conjugates of cheno and urso which increased during treatment with the respective bile acids. The serum levels of cholate and deoxycholate remained normal, although their concentrations in bile decreased considerably during treatment with cheno and urso, respectively. Further studies have to establish whether serum determinations of lithocholate can also be used in man to study the role of this bile acid in the liver function abnormalities which develop in some patients treated with cheno or urso and/or whether measurement of serum cheno and urso could be useful for the monitoring of patient compliance with the respective bile acid treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Danzinger RG, Hofmann AF, Schoenfield LJ, et al.: Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 286:1–8, 1972

    Google Scholar 

  2. Thistle JL, Hofmann AF: Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N Engl J Med 289:655–659, 1973

    Google Scholar 

  3. Iser JH, Dowling RH, Mok HYI, et al: Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med 293:378–383, 1975

    Google Scholar 

  4. Fromm H, Eschler A, Tollner D, et al:In vivo dissolving of gallstones: The effect of chenodeoxycholic acid. Dtsch Med Wochenschr 100:1619–1624, 1975

    Google Scholar 

  5. Coyne MJ, Bonorris GG, Chung A, et al: Treatment of gallstones with chenodeoxycholic acid and phenobarbital. N Engl J Med 292:604–607, 1975

    Google Scholar 

  6. Fromm H, Holz-Slomczyk M, Zobl H, et al: Studies of liver function and structure in patients with gallstones before and during treatment with chenodeoxycholic acid. Acta Hepato-Gastroenterol 22:359–369, 1975

    Google Scholar 

  7. Barbara L, Roda E, Roda A, et al: The medical treatment of cholesterol gallstones: Experience with chenodeoxycholic acid. Digestion 14:209–219, 1976

    Google Scholar 

  8. Dowling RH, Hofmann AF, Barbara L: Workshop on Ursodeoxycholic Acid. Lancaster, MTP Press Limited, 1978

    Google Scholar 

  9. Thistle JL, Hofmann AF, Ott BJ, et al: Chenotherapy for gallstone dissolution: I. Efficacy and safety. J Am Med Assoc 239:1041–1046, 1978

    Google Scholar 

  10. Fromm H: Ursodeoxycholic acid for gallstone dissolution: The emergence of a new therapeutic application for an old bile acid.In MM Fisher, CA Goresky, EA Shaffer, SM Strasberg (eds). New York, Plenum Press, 1979, pp 363–370

    Google Scholar 

  11. Nakagawa S, Makino I, Ishizaki T, et al: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 1:367–369, 1977

    Google Scholar 

  12. Maton PN, Murphy GM, Dowling RH: Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet 2:1297–1301, 1977

    Google Scholar 

  13. Dyrszka H, Salen G, Zaki FG, et al: Hepatic toxicity in the rhesus monkey treated with chenodeoxycholic acid for 6 months: Biochemical and ultrastructural studies. Gastroenterology 70:93–104, 1976

    Google Scholar 

  14. McSherry CK, Morrissey KP, Swarm RL, et al: Chenodeoxycholic acid induced liver injury in pregnant and neonatal baboons. Ann Surg 184:490–499, 1976

    Google Scholar 

  15. Fedorowski T, Salen G, Zaki FG: Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid in the rhesus monkey. Biochemical and ultrastructural studies. Gastroenterology 74:75–81, 1978

    Google Scholar 

  16. Sarva RP, Fromm H, Farivar S, et al: Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and on bile acid composition in the rhesus monkey. Gastroenterology 79:629–636, 1980

    Google Scholar 

  17. Gadacz TR, Allan RN, Mack E, et al: Impaired lithocholate sulfation in the rhesus monkey: A possible mechanism for chenodeoxycholate toxicity. Gastroenterology 70:1125–1129, 1976

    Google Scholar 

  18. Palmer RH, Bolt MG: Bile acid sulfates. I. Synthesis of lithocholic acid sulfates and their identification in human bile. J Lipid Res 12:671–679, 1971

    Google Scholar 

  19. Stiehl A: Sulfation of bile salts: A new metabolic pathway. Digestion 11:406–413, 1974

    Google Scholar 

  20. Cowen AE, Korman MG, Hofmann AF: Metabolism of lithocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine and their sulfates. Gastroenterology 69:59–66, 1975

    Google Scholar 

  21. Cowen AE, Korman MG, Hofmann AF, et al: Metabolism of lithocholate in healthy man. II. Enterohepatic circulation. Gastroenterology 69:67–76, 1975

    Google Scholar 

  22. Cowen AE, Korman MG, Hofmann AF: Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives. Gastroenterology 69:77–82, 1975

    Google Scholar 

  23. Bell GD, Mok HYI, Thwe M, et al: Liver structure and function in cholelithiasis: Effect of chenodeoxycholic acid. Gut 15:165–172, 1974

    Google Scholar 

  24. Mok HYI, Bell GD, Dowling RH: Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side effect in patients with gallstones. Lancet 1:253–257, 1974

    Google Scholar 

  25. Menghini G, Pallotta B: Marked increase in serum levels of liver enzymes in patients receiving chenic acid and phenobarbital for gallstone dissolution. Digestion 14:163–169, 1976

    Google Scholar 

  26. Bateson MC, Hopwood D, Bouchier IAD: Effect of gallstone-dissolution therapy on human liver structure. Am J Dig Dis 22:293–299, 1977

    Google Scholar 

  27. Sue SO, Pearlman BJ, Marks JW: Lithocholate sulfation: A determinant of hypertransaminasemia in chenodeoxycholate-treated gallstone patients. Gastroenterology 78:1324, 1980 (abstract)

    Google Scholar 

  28. Allan RN, Thistle JL, Hofmann A, et al: Lithocholate metabolism during chenotherapy for gallstone dissolution. I. Serum levels of sulphated and unsulphated lihocholates. Gut 17:405–412, 1976

    Google Scholar 

  29. Barbara L, Roda A, Roda E, et al: Diurnal variations of serum primary bile acids in healthy subjects and hepatobiliary disease patients. Rendic Gastroenterol 8:194–198, 1976

    Google Scholar 

  30. LaRusso NF, Hoffman NE, Korman MG, et al: Determinants of fasting and postprandial serum bile acid levels in healthy man. Am J Dig Dis 23:385–391, 1978

    Google Scholar 

  31. Shaffer EA, Gordon ER: Serum bile acids as related to bile acid secretion in liver disease. Am J Dig Dis 23:392–397, 1978

    Google Scholar 

  32. Gilmore IT, Hofmann AF: Altered drug metabolism and elevated serum bile acids in liver disease: A unified pharmacokinetic explanation. Gastroenterology 78:177–179, 1980 (editorial)

    Google Scholar 

  33. Whiting MJ, Watts JMcK: Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy. Gastroenterology 78:220–225, 1980

    Google Scholar 

  34. Fromm H, Erbler HC, Eschler A: Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones. Klin Wochenschr 54:1125–1131, 1976

    Google Scholar 

  35. Fromm H, Carlson GL, Hofmann AF, et al: Metabolism in man of 7-ketolithocholic acid: Precursor of cheno- and ursodeoxycholic acids. Am J Physiol 239:G161-G166, 1980

    Google Scholar 

  36. Makino I, Shinozaki K, Nakagawa S, et al: Measurement of sulfated and nonsulfated bile acids in human serum and urine. J Lipid Res 15:132–138, 1974

    Google Scholar 

  37. Roda A, Roda E, Aldini R, et al: Development, validation, and application of a single-tube radioimmunoassay for cholic and chenodeoxycholic conjugated bile acids in human serum. Clin Chem 23:2107–2112, 1977

    Google Scholar 

  38. Roda A, Roda E, Festi D, et al: A radioimmunoassay of primary bile acid conjugates in human serum. Ric Clin Lab 7:162–178, 1977

    Google Scholar 

  39. Bailey NTJ: Statistical Methods in Biology. London, The English Universities Press, 1968

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Unit, Montefiore Hospital, Department of Medicine, University of Pittsburgh School of Medicine, 3459 Fifth Avenue, 15213, Pittsburgh, Pennsylvania

    F. Bazzoli, A. Roda, H. Fromm, R. P. Sarva, E. Roda & L. Barbara

  2. Istituto di Clinica Medica III dell'Universita degli Studi di Bologna, Italy

    F. Bazzoli, A. Roda, H. Fromm, R. P. Sarva, E. Roda & L. Barbara

Authors
  1. F. Bazzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Roda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Fromm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. P. Sarva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Roda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Barbara
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The study was supported in part by grant AM-19689 from the National Institutes of Health. Dr. Fromm is recipient of Research Career Development Award AM-00290 from the National Bazzoli is a Research Fellow in Gastroenterology sponsored by the National Council of Research, Rome, Italy, and by NATO.

The skillful technical assistance of Prafulla Amin and Susan Ceryak is gratefully acknowledged.

A preliminary report of this work was published in abstract form inGastroenterology (78:1301, 1980).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bazzoli, F., Roda, A., Fromm, H. et al. Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey. Digest Dis Sci 27, 417–424 (1982). https://doi.org/10.1007/BF01295650

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01295650

Keywords

Search

Navigation